MoneyWorks4Me

Alivus Life Sciences informs about analyst meet

09 Jun 2025 Evaluate
Alivus Life Sciences has informed that pursuant to Regulation 30 and Para A of Part A of Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, details of the meetings with Investor/Analyst which will be held on June 12, 2025 and attended by the representatives of the Company is enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1231.85
Cipla 1325.00
Lupin 1955.80
Zydus Lifesciences 1124.30
View more..